Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System

View source ↗

Summary

The PRECISION II study is evaluating how accurately the LabPatch Glucose Sensing System measures glucose in people with Type 1 diabetes mellitus and Type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LabPatch Glucose Sensing System

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Status: RECRUITING